AD |
Alzheimer’s disease |
ASCT1 |
Alanine-serine-cysteine transporter 1 |
BBB |
Blood–Brain Barrier |
CSF |
Cerebrospinal fluid |
D-ser |
Dextro (D)-serine |
FAD |
Familial Alzheimer’s Disease |
GluN2 |
Glutamate ionotrophic receptor NMDA type subunit 2 |
GluN3 |
Glutamate ionotrophic receptor NMDA type subunit 3 |
KOMP |
Knockout Mouse Project |
L-DOPA |
Levodopa |
L-ser |
Levo (L)-serine |
LTP |
Long-term potentiation |
MDD |
Major Depressive Disorder |
NMDA |
N-methyl-D-aspartate |
PD |
Parkinson’s disease |
PCP |
Phencyclidine |
PHGDH |
Phosphoglycerate dehydrogenase |
SLC1A4 |
Solute carrier family 1 member 4 gene |
SLC1A4 |
Solute carrier family 1 member 4 protein |
SNP |
Single nucleotide polymorphism |
SPATCCM |
Spastic tetraplegia, thin corpus callosum and progressive microcephaly |
TBI |
Traumatic Brain Injury |